Published • loading... • Updated
French biopharma company buys US biotech in $1.75B deal: Here’s the drug they’re after
Summary by Mass Live
1 Articles
1 Articles
French biopharma company buys US biotech in $1.75B deal: Here’s the drug they’re after
A French pharmaceutical company is betting up to $1.75 billion on a Bay Area biotech — and the bulk of that money only pays out if a single drug, tested so far on fewer than 20 patients, actually works.
·Springfield, United States
Read Full Article
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
